Cannabis: A new approach to medicine
RIDDHI NAIK
THADOMAL SHAHANI ENGINEERING COLLEGE
Rina.16.rn@gmail.com
Introduction
We all have extensively learned about marijuana as a drug at some point in our lives. Its consumption is known to cause intoxicating effects on individuals.
But did you know, several notable scientists and doctors have dedicated their lives to research and understanding the uses of this herb that once held significance in the community for medical benefits.
Now we all would agree that cannabis somehow affects the brain and the neural systems since its most obvious and harmful effect is its ability to intoxicate. After decades of research, a whole new system was discovered that reacted with the active compounds of cannabis called the cannabinoids and thus was named ‘The Endocannabinoid System’. This unique system of the brain and body affects various vital regulatory functions.
History of Cannabis
Cannabis is a genus of flowering plants of the family Cannabaceae with over 650 species. Three species recognized as Cannabis sativa, Cannabis indica, and Cannabis ruderalis can be dealt with as subspecies of a single species, C. sativa. The genus is broadly universal for being indigenous to and originating from Central Asia.
It was earlier especially valued for its fiber, food, and pharmacological effects. Chinese scriptures are dating back to 100BCE, noteworthy Egyptian engravings and Indian medicinal studies prove this. Medicinal uses included remedies for pain, epilepsy, grief, glaucoma, anti-inflammatory, anti-anxiety, tetanus, tinnitus, relief from burns, and a lot more.
Now, there are approximately 540 chemical compounds identified within the plant out of which 60-100 are termed cannabinoids. Cannabinoids and terpenes develop in the resin glands, or trichomes, at the flower and leaves of the cannabis plant. The primary and relatively vital ones being THC (tetrahydrocannabinol) and CBD (cannabidiol).
Endocannabinoid system
The Endocannabinoid system or ECS is an actively complicated cell signaling system. It maintains the homeostasis of cellular messages through the regulation of neurotransmitters, playing a crucial role in pain sensitivity and the immune system. The main components of ECS consist of endocannabinoids, cannabinoid receptors, and enzymes.
Endocannabinoids: These are endogenous lipid-based naturally occurring neurotransmitters that engage cannabinoid receptors. The two mainly identified endocannabinoids are anandamide and 2-AG. Their precursors are present in the lipid membranes. They are liberated into the extracellular space on-demand as opposed to other neurotransmitters which are synthesized ahead of time and are stored in synaptic vesicles.
Cannabinoid Receptors: ECS is primarily mediated by CB1 and CB2 receptors. Both are G protein-coupled receptors(GPCR). It inhibits adenyl cyclases, voltage-dependent calcium channels and activates MAP kinases inwardly rectifying K channels. CB1 is expressed majorly in the central nervous system (endocannabinoid target to relieve pain). CB2 is expressed majorly in the peripheral nervous system (endocannabinoid targets immune cells on inflammation).
Enzymes: These breakdown endocannabinoids after carrying out a response that is needed. There are 2 main enzymes fatty acid amide hydrolase ( breakdown anandamide) and monoacylglycerol acid lipase (breakdown 2-AG).
Figure 1: The Endocannabinoid System
To explain the mechanism of ECS in simple words:
In the event of signal transmission, the brain releases neurotransmitters (GABA, serotonin, norepinephrine) which are received by the cell and further passed on to the next cell. However, if the message sent is “off” which is usually a neuroexcitation, the cell gets perturbed. Calcium rushes in signaling the body to secrete its endocannabinoid. Endocannabinoid binds with cannabinoid receptor which signals the neurotransmitters to stop.
A negative feedback loop is achieved by activating a postsynaptic neuron which synthesizes and releases endocannabinoids as they target cannabinoid receptors. For instance, in case of seizures, anxiety attacks, and nausea caused by chemotherapy or pain, the cell wants to send a message backward to turn it off. Binding and stimulating CB1 receptors in instances of pain will up-regulate GABA neurotransmitters, thus reducing the pain signals through the brain.
Endocannabinoid System and phytocannabinoids
By targeting the cannabinoid receptors in the ECS, the plant compounds can bring in their therapeutic effects by causing an “override” signal.
Cannabis plants contain two vital compounds tetrahydrocannabinol (THC) which is the most active cannabinoid that targets the CB1 receptor predominantly and beta-caryophyllene (terpene) which predominantly targets the CB2 receptor. These imitate endocannabinoids in the system. The body uses phytocannabinoids as endocannabinoids.
Side effects
THC is the only psychoactive component. In very rare cases, extremely high doses could cause hallucinations. The main concern usually is substance abuse. Marijuana smokers undergo dependency. The brain stops the production of endocannabinoid receptors due to which irritability, mood swings, and sleep problems are caused after terminating use. This is however different than addiction. There is lesser data available for studies on addiction to cannabis.
Conclusion
While unearthing metabolic pathways of phytocannabinoids scientists discovered one of the most important molecular signaling systems of the body that is responsible for a wide range of regulatory functions and homeostasis of the body. Phytocannabinoids can mimic human endogenous functions, making them a very powerful tool for the correction of disorders of the brain and neural connections. Due to the nature of the rate of degradation of cannabinoids, it does not have many long-term side effects, unlike the other drugs on the market. Cannabis holds immense potential in finding relief and even cure to various diseases.
Reference (Jun-21-A1)
